星巴克(SBUX.US)內地非咖啡產品降價 平均降幅約5元人民幣
美國咖啡店連鎖星巴克(SBUX.US)在其內地微信賬戶宣布,明日(10日)起下調非咖啡產品冰飲產品售價,涉及星冰樂、冰搖茶及茶拿鐵等十多款產品,平均價格降幅約5元人民幣,每杯最低價格23元人民幣。
《路透》引述消息報道,公司並沒有減價以回應競爭,但尋求在下午時段吸引更多顧客。消息稱,公司可能有長期策略,集中於消費者在下午對非咖啡飲品的需求。
報道指,瑞幸咖啡(LKNCY.US)及庫迪咖啡把飲品價格降至最低9.9元或8.9元人民幣,京東-SW(09618.HK)及阿里-W(09988.HK)進入餐飲外賣市場令競爭加劇。內地消費者可透過優惠及優惠券,以最低2.9元人民幣購買飲品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.